Keyphrases
Denmark
100%
Confidence Interval
88%
Meta-analysis
42%
Randomized Controlled Trial
40%
Hazard Ratio
39%
National Cohort Study
36%
Randomized Clinical Trial
34%
Placebo
33%
Risk Factors
32%
Systematic Meta-analysis
28%
Odds Ratio
28%
Type 2 Diabetes Mellitus (T2DM)
27%
Multiple Sclerosis
27%
Rheumatoid Arthritis
27%
High Risk
26%
Type 1 Diabetes Mellitus (T1DM)
25%
Heart Failure
24%
Copenhagen
23%
Randomized Trial
23%
Atrial Fibrillation
22%
Europe
21%
Tumor
21%
Quality of Life
21%
Magnetic Resonance Imaging
21%
Migraine
20%
COVID-19
20%
Clinical Outcomes
20%
All-cause Mortality
20%
Comorbidity
19%
Overall Survival
19%
Clinical Trials
19%
Myocardial Infarction
18%
Type I Diabetes
18%
Diabetes
17%
Healthy Controls
17%
Breast Cancer
16%
Inflammation
16%
Out-of-hospital Cardiac Arrest
16%
Body Mass Index
16%
Headache
15%
Cardiovascular Disease
15%
Chemotherapy
15%
Positron Emission Tomography
15%
Type 2 Diabetic Patients
15%
Cystic Fibrosis
14%
Adverse Events
14%
Pseudomonas Aeruginosa (P. aeruginosa)
14%
Alzheimer's Disease
14%
Health-related Quality of Life
14%
Ultrasound
14%
Cardiovascular Risk
14%
Intensive Care Unit
13%
Incidence Rate
13%
Prospective Cohort Study
13%
Randomized Placebo-controlled Trial
13%
Pregnant Women
12%
Physical Activity
12%
ST-elevation Myocardial Infarction (STEMI)
12%
Obesity
12%
Non-associated
12%
Cancer Patients
12%
Ovarian Cancer
12%
Population-based Study
12%
Clinical Practice
12%
Older Adults
11%
Healthy Individuals
11%
Radiotherapy
11%
Spinal Cord Injury
11%
Acute Myocardial Infarction
11%
Glucagon-like
11%
Cardiovascular Mortality
11%
Hospitalization
11%
Computed Tomography
11%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
11%
Clinical Analysis
11%
Cerebral Blood Flow
11%
AIMSâ„¢
10%
During Pregnancy
10%
Interleukin-6
10%
Register Study
10%
HIV Patients
10%
Danish Population
10%
Dementia
10%
Genotype
10%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
10%
Prognostic Value
10%
Blood Pressure
10%
Acute Lymphoblastic Leukemia
10%
Adult Patients
10%
Gene Expression
10%
Prostate Cancer
10%
Low Risk
10%
Skeletal muscle
10%
Antiretroviral Therapy
9%
Blood Samples
9%
Cerebrospinal Fluid
9%
Traumatic Brain Injury
9%
People Living with HIV (PLHIV)
9%
Chronic Kidney Disease
9%
Patients with Heart Failure
9%
Medicine and Dentistry
Disease
73%
Cohort Analysis
65%
Systematic Review
49%
Neoplasm
44%
Malignant Neoplasm
41%
Diagnosis
37%
Symptom
36%
Randomized Controlled Trial
35%
Magnetic Resonance Imaging
33%
Meta-Analysis
33%
Prevalence
32%
Hazard Ratio
31%
Placebo
30%
Infection
29%
Heart Failure
28%
Quality of Life
28%
Breast Cancer
26%
Biological Marker
26%
Human Immunodeficiency Virus
25%
Randomized Clinical Trial
24%
Diabetes
24%
Cardiovascular System
23%
Apoplexy
22%
Odds Ratio
21%
Maturity Onset Diabetes of the Young
21%
Adverse Event
21%
Clinical Trial
21%
Childbirth
20%
Surgery
19%
Pediatrics
19%
Injury
19%
Cardiovascular Disease
18%
Radiation Therapy
18%
Overall Survival
18%
Observational Study
17%
COVID-19
17%
Atrial Fibrillation
17%
Rheumatoid Arthritis
16%
Migraine
15%
Ovarian Cancer
15%
Intensive Care Unit
15%
Body Mass Index
15%
Positron Emission Tomography
15%
Percutaneous Aortic Valve Replacement
14%
Population
14%
Cross Sectional Study
13%
Insulin Dependent Diabetes Mellitus
13%
Computer Assisted Tomography
13%
Drug Therapy
13%
Recurrent Disease
13%
Out of Hospital Cardiac Arrest
13%
Headache
13%
Myocardial Infarction
12%
Diabetes Mellitus
12%
Bleeding
12%
Prostate Cancer
12%
Biopsy
11%
Multiple Sclerosis
11%
Adolescent
11%
Acute Lymphoblastic Leukemia
11%
Rehabilitation Engineering
11%
Proportional Hazards Model
10%
Positron Emission Tomography-Computed Tomography
10%
Clinician
10%
Arm
10%
All Cause Mortality
10%
Physical Activity
10%
Positron Emission Tomography
10%
Prospective Cohort Study
9%
Blood Pressure
9%
Exercise
9%
Health Care Cost
9%
Hemodynamic
9%
Wart Virus
9%
Prospective Study
9%
Patient-Reported Outcome
9%
Traumatic Brain Injury
9%
Skeletal Muscle
9%
Neonatal Infant
9%
Metastatic Carcinoma
9%
Logistic Regression Analysis
9%
Heart Arrest
8%
Resuscitation
8%
Coronary Artery Disease
8%
Lung Cancer
8%
Patient with Type 2 Diabetes
8%
In Vitro
8%
Case-Control Study
8%
Spinal Cord Injury
8%
Ischemic Heart Disease
8%
Combination Therapy
8%
Intensive Care
8%
Surgeon
8%
ST Segment Elevation Myocardial Infarction
8%
Cardiovascular Risk
8%
Chronic Kidney Disease
7%
Kidney Function
7%
Cohort Effect
7%
Nodular Melanoma
7%
Cancer
7%